NCT03825484 2025-06-13Expanded Access Program (EAP) for Participants With Advanced Cancers and Fibroblast Growth Factor Receptor (FGFR) Genetic Alterations Who Have Exhausted All Treatment OptionsJanssen Scientific Affairs, LLCApproved for marketing